Madison Clarke
In 2014, the US military responded to the Ebola virus epidemic in West Africa by deploying troops to support a range of activities, including building mobile and fixed labs, training locals in using personal protective equipment, and providing security. The US troops were not assigned to care for Ebola patients but were trained to protect themselves from the virus. While there is limited information on whether US troops received Ebola vaccines specifically, the Obama administration prioritized developing countermeasures and treatments for Ebola. As of 2022, the first and only approved vaccine in the US against the Zaire ebolavirus is rVSV-ZEBOV, branded as Ervebo, which was approved in December 2019.
| Characteristics | Values |
|---|---|
| US troops deployed to West Africa | Yes |
| US troops received Ebola vaccines | Not found |
| US response to the Ebola epidemic | Led by the US military; included providing training, protective equipment, test kits, funding, and community health worker support |
| Ebola vaccine development status | Several candidates in various stages of development; Phase 1 clinical trials have been conducted |
Explore related products
What You'll Learn
US troops did not directly treat Ebola patients
In September 2014, President Obama announced that the U.S. military would lead the fight against the Ebola virus in West Africa. This deployment was called Operation United Assistance. The operation involved transporting supplies to Liberia and scouting out sites to build treatment centres.
Although U.S. troops were deployed to West Africa, they did not provide direct care for Ebola patients. Marine Corps Maj. Gen. James Lariviere told Congress that the troops had a "no-touch policy and a three-foot separation rule with local nationals". The Chief of Staff of the United States Army, Raymond T. Odierno, ordered a 21-day quarantine for all soldiers returning from Operation United Assistance.
The psychological impact of deploying in support of the U.S. response to Ebola was an important consideration. Previous studies had identified the psychological impact of responding to an outbreak, but these studies were limited to medical personnel. The Walter Reed Army Institute of Research assessed the mental health of deploying troops and identified troop concerns. These assessments were designed to gather lessons that could be used as a reference for similar operations in the future.
Vaccination Records: Can Businesses Legally Ask for Proof?
You may want to see also
Explore related products
The US military trained personnel to avoid exposure to Ebola
In 2014, the US military deployed approximately 2,500 service members to Liberia to support the government in response to the Ebola outbreak in West Africa. Their primary missions were to construct Ebola treatment units (ETUs), train local health care workers to staff the units, and provide laboratory testing capacity for Ebola.
The US military also provided training on the proper use of personal protective equipment (PPE) to local nationals. In addition, subject matter experts in infectious diseases, preventive medicine, and entomology briefed deploying personnel on region-specific medical threats and available countermeasures, such as personal protective measures, vaccines, and drugs.
Despite the training, more than 40% of soldiers were still concerned about potential health threats. This apparent contradiction between confidence and concern suggests that even with training, soldier concerns may not be alleviated. However, the preventive health measures during deployment and the fact that none of the military team contracted a serious disease may explain why the rate of concern dropped by half during deployment.
College Students: Get Your Vaccine in NY!
You may want to see also
Explore related products
The US military's response to the Ebola crisis
In September 2014, amidst the deadliest Ebola outbreak in history, President Obama announced that the U.S. military would lead the fight against the virus in West Africa. The U.S. response to the Ebola crisis was dubbed Operation United Assistance. The U.S. military's involvement in the operation included sending a field-deployable hospital to Liberia, providing more than 10,000 Ebola test kits to the Liberian Institute of Biological Research and Sierra Leone's Kenema Government Hospital, and supplying personal protective equipment and training to local medical professionals in affected regions. The U.S. government also helped recruit and organize medical personnel to staff Ebola Treatment Units and established a site to train healthcare providers to safely provide direct medical care to patients.
The U.S. Public Health Service Commissioned Corps deployed 65 officers to Liberia to manage and staff a Department of Defense (DoD) hospital for healthcare workers who became infected with Ebola. The Monrovia Medical Unit, a 25-bed field hospital for local healthcare workers, opened in November 2014 in Liberia. The plan was for U.S. Public Health Service officers to care for Ebola-infected healthcare workers at this facility.
In addition to these efforts, the U.S. military also focused on the psychological impact of deploying troops in support of Operation United Assistance. Researchers at the Walter Reed Army Institute of Research assessed the mental health of deploying troops and identified their concerns. This assessment aimed to gather lessons that could be referenced in similar future operations. The deploying force was trained to avoid exposure to Ebola and other endemic diseases, although it was considered unlikely that they would come into contact with the virus. Nevertheless, the extensive media coverage of the outbreak highlighted the potential threat and uncertainty regarding the length of deployment and potential for subsequent quarantine, which could have impacted the mental health of the troops.
Polio Vaccine: Synonyms and Their Significance
You may want to see also
The Obama Administration's Ebola response
In 2014, the Obama administration responded to the Ebola outbreak in West Africa by deploying US military forces and healthcare workers to the region. President Obama acknowledged that the epidemic was "going to get worse before it gets better". The US response aimed to contain the disease at its source while also preparing the US healthcare system for potential Ebola cases at home. Republican and Democratic lawmakers approved $5.4 billion in emergency funding for a comprehensive Ebola response, including vaccine development and treatment advancements.
The Obama administration recognised the critical role of American healthcare workers in Africa, describing them as the "strategic and operational backbone" of the US response. Efforts focused on increasing Ebola treatment units, burial teams, and medical personnel, equipment, and supplies. An aggressive education campaign was also launched in affected countries.
To protect Americans, the Centers for Disease Control and Prevention (CDC) and the Department of Homeland Security implemented entry screening at major airports, such as John F. Kennedy International Airport in New York, to detect signs of Ebola or potential exposure among arriving passengers from affected countries.
The Obama administration emphasised the importance of proper training and coordination for US doctors and healthcare professionals to effectively manage Ebola cases in the United States. Updated guidelines were issued by the CDC to monitor and guide healthcare workers returning from affected countries.
The administration's comprehensive response involved a whole-of-government approach, working with international partners to lead the global response to the Ebola epidemic in West Africa.
Doctors and Vaccines: Monetary Compensation Explained
You may want to see also
The first Ebola vaccine
The first proven vaccine against Ebola was the VSV-EBOV vaccine, which was found to be 70-100% effective against the virus. The vaccine was developed following the West African Ebola crisis, which began in late 2013. The World Health Organization (WHO) reported a "rapidly evolving" outbreak of Ebola in southeastern Guinea on March 23, 2014, with 49 cases and 29 deaths. This outbreak was larger than about half of all previous known Ebola outbreaks.
The development of the VSV-EBOV vaccine was a collaborative effort involving researchers, field workers, and funding from the Canadian government. The vaccine was first tested on animals, where it showed increased survival rates even when given as late as 48 hours after exposure. The efficacy of the vaccine was further demonstrated in a study conducted in Guinea during the 2014-2016 outbreak, where 3,537 contacts and contacts of contacts of individuals with laboratory-confirmed Ebola received either immediate or 21-day delayed vaccination. This study found the vaccine to be 100% effective in preventing Ebola cases with symptom onset greater than ten days after vaccination.
The development and approval of these vaccines marked a crucial step in the fight against Ebola, a severe illness with a high case fatality rate. The availability of vaccines has helped improve health system preparedness and resiliency, and ongoing research continues to guide funding decisions and strategies for vaccine use and distribution.
Vaccine Trials: Exposure to Virus?
You may want to see also
Frequently asked questions
Yes, in 2014, US troops were provided training and were certified to work in Ebola-affected areas of West Africa.
The Ebola vaccine is an investigational vaccine developed by the National Institutes of Health (NIH). It recently entered Phase 1 clinical trials in 2014.
The most commonly reported side effects of the Ebola vaccine are pain, swelling and redness at the injection site, as well as headache, fever, joint and muscle aches, and fatigue.
The Ebola vaccine has been found to be 70-100% effective against the Ebola virus. In a study conducted in Guinea during the 2014-2016 outbreak, the vaccine was determined to be 100% effective in preventing Ebola when administered immediately after exposure.
The US government has played a significant role in addressing the Ebola outbreak in West Africa. They have provided funding, personal protective equipment, mobile labs, and other resources. They have also collaborated with international partners and focused on educating healthcare workers and developing countermeasures, such as vaccines and treatment centres.
